• Mashup Score: 58

    Using a mouse tumor model with inducible cGAS expression, Herbst et al. show that cancer-cell-derived cGAMP triggers a sustained type I interferon response, enhancing CD8+ T cell-dependent tumor restriction. However, STING-expressing CD8+ T cells exhibit reduced proliferation and survival. Thus, STING signaling acts as a checkpoint balancing anti-tumor immunity.

    Tweet Tweets with this article
    • Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells https://t.co/3FrYZD1u1s https://t.co/tIB31LeUtK